An open trial of clozapine was carried out in five patients with childhood-onset schizophrenia (COS). The standard protocol for administering and monitoring of clozapine was followed. Psychopathology was measured using the Brief Psychiatric Rating Scale and global clinical improvement was rated by a parent and two clinicians in each case. The level of improvement in positive symptoms was greater than that in negative symptoms with no effect on ritualistic behaviour. Global clinical improvement was substantial. No serious side-effects (seizures, agranulocytosis) were observed. The need to assess the differential clinical effects and establish the role of clozapine as a possible first choice antipsychotic in COS is highlighted.
American Psychiatric Association
. (1994). The diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Press.
2.
Andersen, P.H.
, & Braestrup, C. (1986). Evidence for different states of the dopamine D1 receptor: Clozapine and fluperlapine may preferentially label an adenylate cyclase- coupled state of the D1 receptor. Journal of Neurochemistry, 74, 1822-1831.
3.
Bilder, R.M.
, Lipschutz-Broch, L., Reiter, G., Geisler, S.H., Mayerhoff, D.I., & Lieberman, J.A. (1992). Intellectual deficits in first-episode schizophrenia: Evidence for progressive deterioration. Schizophrenia Bulletin, 18, 437-448.
4.
Birmaher, B.
, Baker, R., Kapur, S., Quintana, H., & Ganguli, R. (1992). Clozapine for the treatment of adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 160-164.
5.
Breier, A.
, Buchanan, R.W., Kirkpatrick, B., Davis, O., Irish, D., Summerfelt, A., & Carpenter, W.T. (1994). Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. American Journal of Psychiatry, 151, 20-26.
6.
Carpenter, W.T.
, Conley, R.R., Buchanan, R.W., Breier, A., & Tammings, C.A. (1995). Patient response and resource management: Another view of clozapine treatment of schizophrenia. American Journal of Psychiatry, 152, 827-832.
7.
Frazier, J.A.
, Gordon, C.T., McKenna, K., Lenane, M.C., Jih, D., & Rapoport, J.L. (1994). An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 658-663.
8.
Hagger, C.
, Buckley, P., Kenny, J.T., Friedman, L., Ubogy, D., & Meltzer, H.Y. (1993). Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry, 34, 702-712.
9.
Jacobsen, L.K.
, & Rapoport, J.L. (1998). Research update: Childhood-onset schizophrenia: Implications of clinical and neurobiological research. Journal of Child Psychology and Psychiatry, 39, 101-113.
10.
Jacobsen, L.K.
, Walker, M.C., Edwards, J.E., Chappell, P.B., & Woolston, J.L. (1994). Clozapine in the treatment of a young adolescent with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 645-650.
11.
Kane, J.M.
, Honigfeld, S., Singer, J., & Meltzer, H. (1988). Clozapine for the treatment-resistant schizophrenia: A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789-796.
12.
Kaplan, H.I.
, & Sadock, B.J. (1995). Comprehensive textbook of psychiatry (6th ed.). Baltimore: Williams & Wilkins.
13.
Kolvin, I.
, Ounsted, C., Humphrey, M., & Mcnay, A. (1971). Studies in childhood psychoses: II. The phenomenology of childhood psychoses. British Journal of Psychiatry, 118, 385-395.
14.
Kumra, S.
, Frazier, J.A., Jacobsen, L.K., McKenna, K., Gordon, C.T., Lenane, M.C., Hamburger, S.D., Smith, A.K., Albus, K.E., Alaghband-Rad, J., & Rapoport, J.L. (1996). Childhood-onset schizophrenia: A double-blind clozapine–haloperidol comparison. Archives of General Psychiatry, 53, 1090-1097.
15.
Kumra, S.
, Jacobsen, L.K., Lenane, M.C., Karp, B., Frazier, J.A., Smith, A.K., Bedwell, J., Lee, P., Malanga, C.J., Hamburger, S., & Rapoport, J.L. (1998). Childhood-onset schizophrenia: An open-label study of olanzapine in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 377-385.
16.
Mozes, T.
, Toren, P., Chernauzan, N., Mester, R., Yoran-Hegesh, R., Blumensohn, R., & Weizman, A. (1994). Clozapine treatment in very early onset schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 65-70.
Quintana, H.
, & Keshavan, M. (1995). Case study: Risperidone in children and adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1292-1296.
19.
Remschmidt, H.
, Schultz, E., & Martin, M. (1994). An open trial of clozapine in 36 adolescents with schizophrenia. Journal of Child and Adolescent Psychopharmacology, 4, 31-41.
20.
Siefen, G.
, & Remschmidt, H. (1986). Behandlungsegebnisse mit clozapin bei schizophrenen Jugendlichen. Z Kinder Jugenpsychiatry, 14, 245-257.
21.
Srinivasan, T.N.
, & Latha, S. (1997). Use of clozapine in childhood schizophrenia.Indian Journal of Psychiatry, 39, 262-264.
22.
Towbin, K.E.
, Dykens, E.M., & Pugliese, R.G. (1994). Clozapine for early developmental delays with childhood-onset schizophrenia: Protocol and 15-month outcome. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 651-657.
23.
Turetz, M.
, Mozes, T., Toren, P., Chernauzan, N., Yoran-Hegesh, R., Mester, R., Wittenberg, N., Tyano, S., & Weizman, A. (1997). An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia. British Journal of Psychiatry, 170, 507-510.
24.
Werry, J.S.
(1992). Child and adolescent (early-onset) schizophrenia: a review in the light of DSM-III-R. Journal of Autism and Developmental Disorders, 22, 601-624.
25.
Werry, J.S.
, & Taylor, E. (1994). Schizophrenic and allied disorders. In M. Rutter, E. Taylor, & L. Hersov (Eds.), Child and adolescent psychiatry: Modern approaches (pp. 594-615). London: Blackwell.
